International Journal of Breast Cancer / 2013 / Article / Tab 4 / Research Article
Use of Cox’s Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete Response Table 4 The estimated proportion of cured patients.
HR status
Clinical response
HER2 status
Histological grade Number of lymph node metastases Estimated proportion of cured patients Negative SD/PD Negative 1 and 2 0 89.3% 1 to 3 78.2% ≥4 44.7% 3 0 83.1% 1 to 3 67.8% ≥4 32.2% Positive 1 and 2 0 81.7% 1 to 3 65.8% ≥4 30.2% 3 0 72.4% 1 to 3 53.0% ≥4 20.2% PR Negative 1 and 2 0 87.3% 1 to 3 74.6% ≥4 39.8% 3 0 80.1% 1 to 3 63.4% ≥4 28.0% Positive 1 and 2 0 78.6% 1 to 3 61.2% ≥4 26.2% 3 0 68.3% 1 to 3 48.1% ≥4 17.2% CR Negative 1 and 2 0 94.9% 1 to 3 89.0% ≥4 64.4% 3 0 91.7% 1 to 3 82.6% ≥4 51.6% Positive 1 and 2 0 90.9% 1 to 3 81.2% ≥4 49.2% 3 0 85.5% 1 to 3 71.7% ≥4 36.3% Positive SD/PD Negative 1 and 2 0 71.2% 1 to 3 51.5% ≥4 19.3% 3 0 59.2% 1 to 3 38.4% ≥4 12.3% Positive 1 and 2 0 57.0% 1 to 3 36.3% ≥4 11.3% 3 0 43.8% 1 to 3 25.1% ≥4 7.0% PR Negative 1 and 2 0 67.0% 1 to 3 46.6% ≥4 16.4% 3 0 54.4% 1 to 3 33.9% ≥4 10.3% Positive 1 and 2 0 52.1% 1 to 3 31.8% ≥4 9.5% 3 0 39.0% 1 to 3 21.5% ≥4 5.8% CR Negative 1 and 2 0 84.7% 1 to 3 70.5% ≥4 34.9% 3 0 76.5% 1 to 3 58.4% ≥4 24.0% Positive 1 and 2 0 74.8% 1 to 3 56.1% ≥4 22.3% 3 0 63.6% 1 to 3 42.9% ≥4 14.4%